Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / PSP Research LLC
Form 13F · Q2 2026

PSP Research LLC

CIK 2106939申報日 2026-07-0913F-HR 在 EDGAR 查看原始申報 ↗
$1.9亿
申報組合市值
75
持倉數量
3
Quarters on record
Top 50
持倉數量

PSP Research LLC——持倉

共 75 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1SPDR SERIES TRUST Spdr Series Trust570,000+100.1%$9020万48.0%
2ISHARES TR Ishares Tr700,000+0.0%$7047万37.5%
3RPRX Royalty Pharma Plc11,000+0.0%$62万0.3%
4NRIX Nurix Therapeutics Inc25,000−12.9%$61万0.3%
5INCY Incyte Corp5,300+0.0%$60万0.3%
6ARGX Argenx Se641+0.0%$59万0.3%
7IRON Disc Medicine Inc8,000+0.0%$59万0.3%
8RAPP Rapport Therapeutics Inc14,000+0.0%$58万0.3%
9RARE Ultragenyx Pharmaceutical In17,000−23.1%$57万0.3%
10TRVI Trevi Therapeutics Inc30,000+0.0%$56万0.3%
11GLUE Monte Rosa Therapeutics Inc23,000−17.9%$56万0.3%
12TGTX Tg Therapeutics Inc10,000−23.1%$55万0.3%
13HALO Halozyme Therapeutics Inc7,000−12.8%$55万0.3%
14IONS Ionis Pharmaceuticals Inc6,800+0.0%$54万0.3%
15PHVS Pharvaris N V15,000−25.0%$52万0.3%
16ARQT Arcutis Biotherapeutics Inc19,700+0.0%$52万0.3%
17AUPH Aurinia Pharmaceuticals Inc30,000+0.0%$51万0.3%
18NBIX Neurocrine Biosciences Inc3,000−22.0%$51万0.3%
19IMVT Immunovant Inc13,000−32.3%$50万0.3%
20ACAD Acadia Pharmaceuticals Inc19,766+0.0%$50万0.3%
21PTCT Ptc Therapeutics Inc6,000+0.0%$49万0.3%
22CLDX Celldex Therapeutics Inc New13,000+0.0%$48万0.3%
23IMCR Immunocore Hldgs Plc15,141+0.0%$48万0.3%
24DFTX Definium Therapeutics Inc10,000−71.3%$47万0.3%
25COGT Cogent Biosciences Inc12,000+0.0%$46万0.2%
26KYMR Kymera Therapeutics Inc4,000−36.5%$46万0.2%
27DYN Dyne Therapeutics Inc20,000+0.0%$44万0.2%
28ALNY Alnylam Pharmaceuticals Inc1,465+0.0%$44万0.2%
29TARS Tarsus Pharmaceuticals Inc7,000+0.0%$44万0.2%
30SNDX Syndax Pharmaceuticals Inc20,000+0.0%$44万0.2%
31EXEL Exelixis Inc8,000−33.0%$44万0.2%
32CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In11,000+0.0%$41万0.2%
33NAMS Newamsterdam Pharma Company12,000−20.0%$41万0.2%
34ASND Ascendis Pharma A/S1,500—$40万0.2%
35LQDA Liquidia Corporation5,000—$40万0.2%
36STOK Stoke Therapeutics Inc12,000+0.0%$39万0.2%
37VKTX Viking Therapeutics Inc10,000−33.3%$39万0.2%
38IMNM Immunome Inc18,000−10.0%$38万0.2%
39PTGX Protagonist Therapeutics Inc3,000+0.0%$37万0.2%
40HRMY Harmony Biosciences Hldgs In10,000−30.0%$36万0.2%
41ELVN Enliven Therapeutics Inc7,000+0.0%$36万0.2%
42SYRE Spyre Therapeutics Inc4,000−22.5%$36万0.2%
43NTLA Intellia Therapeutics Inc20,000−25.7%$34万0.2%
44MDGL Madrigal Pharmaceuticals Inc600+0.0%$32万0.2%
45KNSA Kiniksa Pharmaceuticals Intl5,000−44.4%$32万0.2%
46ALKS Alkermes Plc6,000+0.0%$31万0.2%
47TNGX Tango Therapeutics Inc10,000−30.6%$31万0.2%
48ARDX Ardelyx Inc60,000−25.0%$31万0.2%
49VERA Vera Therapeutics Inc7,000−30.0%$30万0.2%
50MIRM Mirum Pharmaceuticals Inc2,500−50.0%$29万0.2%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。